BB BIOTECH AG 13D and 13G filings for Intra-Cellular Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-12 5:18 pm Purchase |
2020-12-31 | 13G | Intra-Cellular Therapies, Inc. ITCI |
BB BIOTECH AG | 3,538,419 4.400% |
80,000 (+2.31%) |
Filing |